digital what-pharma-stands-gain-technological-innovation 
European Pharmaceutical Review
MAY 2, 2024
What is truly exciting is the diversification of the biologics structures we are seeing in the pipeline of most major pharma and biotech companies” What is truly exciting is the diversification of the biologics structures we are seeing in the pipeline of most major pharma and biotech companies.
Pharma Marketing Network
DECEMBER 17, 2021
The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. HCP Engagement and Pharma Salesforces.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
SEPTEMBER 1, 2023
In the fiercely competitive landscape of the pharma and biotech industries, standing out from the crowd is crucial for success. One strategy that has gained traction in recent years is the Blue Ocean Strategy. How Can Pharma / Biotech Companies Use Blue Red Ocean Strategy?
pharmaphorum
NOVEMBER 30, 2022
Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas.
pharmaphorum
JANUARY 25, 2022
Oskar Möbert, Vice President OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engagement, and increase patient reach. This has dramatic implications on how you work with data, especially in pharma.”
Viseven
JULY 18, 2023
In healthcare, this score is known as the Net Patient Score, reflecting its specific application within the pharma niche. In the pharma niche, the Net Patient Score has gained recognition for its ability to assess patient loyalty and drive improvements in the quality of care.
pharmaphorum
JULY 9, 2021
As demonstrated throughout COVID, digital health is no longer experimental. Digital technologies are proving their value by allowing for better care, improved adherence and a more connected ecosystem between doctors, patients and pharma. There’s an enormous market for similar approaches in other disease areas. “In
Expert insights. Personalized for you.
103 
Let's personalize your content